Immunomodulatory Effects of Quercetin In Patient With Active Rheumatoid Arthritis

作者: Shatha H. Ali , Hayder K. Abbas , Mohammad D. Al-Rekabi , Furqan Hashim , Hamadallah Al-Basaisi

DOI:

关键词:

摘要: Rheumatoid arthritis is an autoimmune systemic inflammatory disease primarily affecting the joints as well other extra-articular tissues. This study was designed to evaluate immunomodulatory effect of different doses quercetin(500mg, 1000mg, 1500mg/day) for rheumatoid in patients treated with conventional modifying antirheumatic drugs (DMARDs). project performed on 160 who fulfilled American College Rheumatology (ACR) criteria diagnosis arthritis. In addition 30 healthy volunteers were invited participate and served a control group. The selected  allocated randomly into four groups, group (A) azathioprine(100 mg/day) plus placebo( starch containing capsules), (B) azathioprine (100mg/day) quercetin (500mg/day), (C) (1000mg/day) (D) azathioprine( 100mg/day) (1500mg/day). Serum level interleukin-6, interleukin-10, intercellular adhesion molecule I (ICAM-1), complements proteins pretreatment after eight weeks treatment. It found that at 1500mg/ day, when added 100mg , significantly(p< 0.05) reduced complement protein 3 (C3) & 4  (C4) levels elevated interleukin-10 level  more than had combined placebo or lower quercetin(500, 1000mg). However, all tested this able significantly (p< reduce molecule-1 compared quercetin-free Oral administration daily (500, 1000, 1500mg) combination 100 mg) produced action through reduction while elevating serum interleukine-10. Keywords : Immunomodulatory, Quercetin, Arthritis, Interleukins, Complements protein.

参考文章(28)
Kenneth T. Calamia, Current and Future Use of Anti-TNF Agents in the Treatment of Autoimmune, Inflammatory Disorders Advances in Experimental Medicine and Biology. ,vol. 528, pp. 545- 549 ,(2004) , 10.1007/0-306-48382-3_110
Steven M. Albelda, C. Wayne Smith, Peter A. Ward, Adhesion molecules and inflammatory injury. The FASEB Journal. ,vol. 8, pp. 504- 512 ,(1994) , 10.1096/FASEBJ.8.8.8181668
Jordan S Pober, Timothy A Springer, Alan H Stolpen, Lynne A Lapierre, Michael A Gimbrone, Walter Fiers, Tommy A Brock, Donna L Mendrick, Michael P Bevilacqua, Activation of cultured human endothelial cells by recombinant lymphotoxin: comparison with tumor necrosis factor and interleukin 1 species. Journal of Immunology. ,vol. 138, pp. 3319- 3324 ,(1987)
C. A. Perry, M. E. Gerritsen, G. E. Ranges, G. F. Ligon, S. A. Phan, W. W. Carley, Chien-Ping Shen, Flavonoids inhibit cytokine-induced endothelial cell adhesion protein gene expression. American Journal of Pathology. ,vol. 147, pp. 278- 292 ,(1995)
Kenneth A. Roebuck, Arshad Rahman, Venkatesh Lakshminarayanan, Kilambi Janakidevi, Asrar B. Malik, H2O2 and Tumor Necrosis Factor-α Activate Intercellular Adhesion Molecule 1 (ICAM-1) Gene Transcription through Distinct cis-Regulatory Elements within the ICAM-1 Promoter Journal of Biological Chemistry. ,vol. 270, pp. 18966- 18974 ,(1995) , 10.1074/JBC.270.32.18966
Zoltan Szekanecz, G. Kenneth Haines, Theodore R. Lin, Lisa A. Harlow, Sergij Goerdt, Ghazi Rayan, Alisa E. Koch, Differential distribution of intercellular adhesion molecules (ICAM-1, ICAM-2, and ICAM-3) and the MS-1 antigen in normal and diseased human synovia: Their possible pathogenetic and clinical significance in rheumatoid arthritis Arthritis & Rheumatism. ,vol. 37, pp. 221- 231 ,(1994) , 10.1002/ART.1780370211
Sashwati Roy, Chandan K. Sen, Hirotsugu Kobuchi, Lester Packer, Antioxidant regulation of phorbol ester-induced adhesion of human Jurkat T-cells to endothelial cells. Free Radical Biology and Medicine. ,vol. 25, pp. 229- 241 ,(1998) , 10.1016/S0891-5849(98)00062-8
Asako Chiba, Shinji Oki, Katsuichi Miyamoto, Hiroshi Hashimoto, Takashi Yamamura, Sachiko Miyake, Suppression of collagen-induced arthritis by natural killer T cell activation with OCH, a sphingosine-truncated analog of α-galactosylceramide Arthritis & Rheumatism. ,vol. 50, pp. 305- 313 ,(2004) , 10.1002/ART.11489
Bente Klarlund Pedersen, Mark Febbraio, Muscle-derived interleukin-6—A possible link between skeletal muscle, adipose tissue, liver, and brain Brain Behavior and Immunity. ,vol. 19, pp. 371- 376 ,(2005) , 10.1016/J.BBI.2005.04.008